newsfilter
← Latest News
GlobeNewswire·

Imara Announces Interim Analysis Data from Forte Phase 2b Clinical Trial of Tovinontrine (IMR-687) in Transfusion-Dependent Subjects with Beta-thalassemia

Positive trend observed in transfusion-dependent subjects treated with higher dose tovinontrine for reduced transfusion burden Tovinontrine was generally well-tolerated in this patient population BOSTON, Nov. 16, 2021 (GLOBE NEWSWIRE) -- Ima